Patents Assigned to ESSENTIAL PHARMACEUTICALS, LLC
  • Publication number: 20130130373
    Abstract: The present disclosure relates, in general to a kit comprising a serum replacement and one or more labile factors, such as growth factors, packaged separately in the kit. It is contemplated that the kit provides advantages to improve cell growth in culture compared to cells cultured not using the kit described herein.
    Type: Application
    Filed: November 9, 2012
    Publication date: May 23, 2013
    Applicant: ESSENTIAL PHARMACEUTICALS, LLC
    Inventor: Essential Pharmaceuticals, LLC